FierceBiotech 2026-01-27 'AI-native' outpatient surgery startup Oath Surgical inks Nvidia partnership
FierceBiotech 2026-01-27 United Therapeutics' bioengineered temporary liver shows promise in phase 1 trial
FierceBiotech 2026-01-27 From gene therapies to … firearms? Italian biotech makes unexpected strategic pivot
FierceBiotech 2026-01-27 After patient death, FDA lifts hold on 1 of 2 late-stage trials testing Intellia’s CRISPR therapy
FierceBiotech 2026-01-27 Qilu programs path into cardiometabolic disease with $120M, AI-enabled Insilico alliance
FierceBiotech 2026-01-26 Ex-CytoDyn CEO sentenced to prison, must pay $5.3M restitution as former CRO leader wins new trial
FierceBiotech 2026-01-26 'Things are looking up': British biotechs consider going public after yearslong IPO drought
FierceBiotech 2026-01-23 Anti-vaccine sentiment pushes Moderna away from new late-stage infectious disease trials
FierceBiotech 2026-01-23 Abbott shares sag as global diagnostic, nutrition business sales declines drag on earnings
FierceBiotech 2026-01-23 J. Craig Venter launches genomics startup designed to boost diagnostic insights
FierceBiotech 2026-01-23 Sanofi plans global filings for key eczema prospect despite mixed phase 3 readout